40255-57-0

Basic information

• Product Name: 2-[(1-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperidin-4-yl)oxy]ethanol hydrochloride (1:1)
• CAS NO: 40255-57-0
• Molecular Formula: C₂₃H₂₈ClF₃N₂O₂S
• Molecular Weight: 488.9938
• Mol File: 40255-57-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 573.2°C at 760 mmHg
• Flash Point: 300.5°C
• Vapor Pressure: 5.59E-14mmHg at 25°C
• CAS DataBase Reference: 2-[(1-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperidin-4-yl)oxy]ethanol hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(1-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperidin-4-yl)oxy]ethanol hydrochloride (1:1)(40255-57-0)
• EPA Substance Registry System: 2-[(1-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperidin-4-yl)oxy]ethanol hydrochloride (1:1)(40255-57-0)

Safety Data

• Hazardous Substances Data: 40255-57-0(Hazardous Substances Data)

Usage

Molecular structure

The compound consists of a piperidin-4-yl group attached to an ethoxyethanol group, with a hydrochloride salt.

Phenothiazin-10-yl group

The compound contains a phenothiazin-10-yl group.

Trifluoromethyl substitution

The phenothiazin-10-yl group has a trifluoromethyl substitution at the 2 position.

Pharmacological properties

The chemical has potential pharmacological properties.

Pharmaceutical applications

The compound may be used in the development of pharmaceutical drugs for the treatment of various conditions.

Hydrochloride salt form

The hydrochloride salt form of the compound makes it more stable and suitable for pharmaceutical applications.

Upstream product

• 40256-14-2 4-piperidone ethylene glycol ketal 
• 1675-46-3 10-(3-chloropropyl)-2-trifluoromethylphenothiazine 

Relevant articles and documents

10-(Piperidin o-alkyl)-phenothiazines

Novel 10-(piperidino-alkyl)-phenothiazines of the formula STR1 wherein X is selected from the group consisting of hydrogen, chlorine, --CF3, --OCH3 and SCH3, B and R are individually selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, Z' is selected from the group consisting of hydrogen and alkyl of 1 to 10 carbon atoms, p is 0 or 1, n is 0, 1 or 2 and A is selected from the group consisting of hydrogen, --COOR2 and --COR1, R2 is linear alkyl of 1 to 15 carbon atoms and R1 is selected from the group consisting of alkyl of 1 to 18 carbon atoms optionally containing a double bond or --O-- and a polymethoxyphenyl and their non-toxic, pharmaceutically acceptable acid addition salts having neuroleptic, analgesic, spasmolytic and antihistaminic activity and their preparation and novel intermediates.